Company Overview
Snapshot
Founded in November 2021 by Ben Omri, Snipe Medical operates with 1-10 employees. The company has raised $2.09 million across 5 funding rounds from 1 investor, Peregrine Ventures. In February 2026, Snipe Medical secured an A Round of funding.
Business overview
Snipe Medical is an early-stage Health Tech & Life Sciences company developing a novel solution for treating lung cancer. The company focuses on medical devices and medical treatment & therapeutics, utilizing Pulsed Electric Fields (PEF) technology to address the lung cancer market.
Strategic signal
In February 2026, Snipe Medical completed an A Round of funding, indicating continued investor confidence in its novel lung cancer treatment solution. This financial milestone suggests the company is progressing in its R&D and moving towards further development and potential commercialization of its PEF technology, signaling positive momentum for its future trajectory in the medical device sector.
Log in to access full profile ›Company Intelligence Q&A
- What was Snipe Medical's most recent funding event?
- In February 2026, Snipe Medical secured an A Round of funding from Peregrine Ventures.
- When did Snipe Medical receive a grant from the Israel Innovation Authority?
- In June 2025, Snipe Medical received a grant from the Israel Innovation Authority and Synergy7.
- What was the total capital raised by Snipe Medical?
- Snipe Medical has raised a total of $2.09 million across its funding rounds.
- Who is the founder of Snipe Medical?
- Ben Omri is the Co-founder & CEO of Snipe Medical.